May 28, 2025, 13:05
Antiphospholipid Syndrome (APS) Management: A 2024 Update and Review
Rheuma Doc – shared a post on X:
“A Nice Summary of Recommendations for the treatment of Antiphospholipid Syndrome (APS) [F.Bashal et al]․
‘Clinical Advances in APS: Evidence-Based Guidance for Rheumatologists and Hematologists.'”
Title: Thrombosis in Rheumatological Diseases
Author: Fozya Bashal
The article is quite interesting and has been featured on Hemostasis Today.
-
Nov 2, 2026, 18:08Jonathan Penm: Antithrombotic Stewardship Optimizes VTE Prophylaxis in ICU Patients
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE